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Surgeon-to-Patient HCV and HBV
Two separate outbreaks of bloodborne pathogen transmission (hepatitis C virus [HCV] and hepatitis B virus [HBV] ) from infected surgeons to patients were reported recently in the Journal of the American Medical Association.
HCV Outbreak
The first outbreak involved a Spanish cardiac surgeon with chronic HCV infection who is believed to have transmitted HCV to five of his patients during open heart surgery. 1 A study of the efficacy of screening blood donors for antibodies to HCV revealed that, of 222 of the surgeon's patients who participated in the study, 6 contracted postoperative HCV despite the use of only seronegative blood for transfusion. All six patients had undergone valve replacement surgery.
The surgeon and five of the six patients with HCV unrelated to transfusions were infected with HCV genotype 3. The genetic nucleotide sequence analysis indicated a common epidemiologic origin of the viruses from the surgeon and five patients. The sixth patient had genotype 1 and was considered to have been infected from another source.
The surgeon reported an overall incidence of about 20 percutaneous injuries per 100 procedures. Most of these injuries occurred in the course of tying wires during closure of the sternum; in many cases, he did not notice the injury until after the procedure. The surgeon had no history of dermatitis and did not recall any occasion when he bled into a patient's wound.
The study could not identify the circumstances and mechanisms of transmission. The authors note that the fact that transmission occurred only among patients undergoing procedures performed by the surgeon, not among those undergoing procedures in which he assisted another surgeon, suggests that transmission was associated with percutaneous injuries, most of which occurred during wire closure of the sternum. This procedure has been associated with a high rate of glove perforation, which almost invariably leads to contact of the surgeon's blood with the patient's open wound.
HBV Outbreak
Dr. Rafael Harpaz and colleagues from the CDC and the University of California at Los Angeles reported an outbreak involving a thoracic surgery resident with acute HBV infection who transmitted HBV to 19 patients during surgery. 2
The investigation was begun when a 47-year-old woman became ill with acute HBV after undergoing a thymectomy. Assistants in the procedure included a thoracic surgery resident who had acute HBV 6 months earlier. The infected surgeon had participated in surgery for 144 susceptible patients in two hospitals; 19 (13%) had evidence of recent HBV infection. One of the hospitals was selected for additional study; none of the 124 susceptible patients of the other thoracic surgeons at this hospital had evidence of recent HBV infection.
No evidence was found for any common source of HBV other than the infected surgeon. The HBsAg subtype and the partial HBV DNA sequences from the surgeon were identical to those in the infected patients. Transmission of the infection was associated with cardiac transplantation, but not with other surgical procedures. The surgeon was positive for hepatitis B e antigen and had a high serum HBV DNA concentration (15 ng/mL). The investigation revealed no deficiencies in the surgeon's infection control practices. The surgeon reported no injuries from sternal wires or other sharp objects. He reported that he always handled sharp objects with an instrument and did not blindly palpate suture needles. He did not wear double gloves, but frequently changed gloves during operations. All surgical staff members, including the surgeon, reported that blood was routinely present on their hands when they removed their gloves after an operation, whether or not visible tears were present in the gloves and regardless of the type of gloves used.
The authors note that, since the 1970s, 29 such clusters of HBV transmission from surgeon to patients have been reported worldwide. Data from these outbreaks indicate that the risk of HBV is increased if the surgeon is HBeAg positive. Transmission during many of these reported outbreaks was related to deficiencies in infection control measures. The authors note that, during this outbreak, it is unlikely that unreported or unrecalled percutaneous exposures would explain such a high rate of transmission. However, thoracic surgery inherently is highly invasive and of long duration, and these features have been linked to glove failure, percutaneous exposures, and HBV transmission.
Nonetheless, the authors suspect that this outbreak may have been related more closely to factors unique to the surgeon than to factors during thoracic surgery. The surgeon had pain over his index finger during prolonged suturing, and, while participating in a 1-hour simulation of suture tying, the surgeon acquired paper-cut-like lesions on his fingers. HBsAg and HBV DNA were isolated from the washings of his hands. It is suspected that such lesions, combined with the failure of his gloves, may have allowed contamination of patients with HBV. The authors note that this outbreak could have been prevented had the surgeon received HBV vaccine.
In an accompanying editorial, Dr. Julie L. Gerberding noted that efforts to prevent surgeon-to-patient transmission of bloodborne infections should not focus on mandatory testing of clinicians, but rather on eliminating the cause of bloodborne exposures. 3 These include the use of blunt suture needles, improved instruments, reinforced gloves, changes in surgical technique, and the use of less invasive alternative procedures. Gerberding also suggested that if a policy had been implemented in 1970 requiring HBV vaccination for matriculation in professional school, for those already in practice, and for continued contact with patients, more than 95% of clinician-to-patient transmission of HBV would have been prevented 
Mad Cows and CJD
The British Government recently announced that there may be a link between bovine spongiform encephalopathy and Creutzfeldt-Jakob Disease (CJD). A committee of scientists set up to advise the government on this issue concluded that the recent outbreak of CJD was linked to the fatal neurologic disease of cattle known as "mad cow disease." A doubling in reported cases of CJD occurred between 1990 and 1994, reaching 55 cases in 1994. Ten cases were discovered in individuals under the age of 41, with some in their teens; normally, CJD affects an older age group. In addition, four dairy farmers whose herds had become infected with mad cow disease developed CJD. The incidence of mad cow disease in Britain has been decreasing after reaching a peak of 900 to 1,000 cases per week in 1992 and 1993. There were approximately 200 to 300 cases per week in January 1996. Experts estimate that more than 1 million infected animals have been consumed already. CJD is a rare disease affecting one per million people. The incubation period is between 10 and 40 years. CJD was thought to be related to bovine spongiform encephalopathy because the two diseases have similar pathology and clinical course. The precise cause of CJD is still a mystery; earlier theories have suggested a virus-like agent, but recent research has advanced a theory that relates both diseases to an abnormal protein in the cell membrane, presumably transmitted through exposure or consumption of infected tissue, which sets off a chain reaction that damages other proteins.
One theory of why it has appeared in British cows is that bovine encephalopathy can be traced to a similar disease in sheep, scrapie, that may have crossed the species barrier in Britain. Experts note that this theory is supported by the practice for years of taking bone and meat remnants from sheep, including brains, grinding it up, and feeding it to cows as a protein supplement. This practice recently was stopped, however.
British Health Secretary Steven Dorrell said it was believed that the 10 new cases of CJD had acquired their disease from exposure to bovine spongiform encephalopathy before 1989. In that year, measures were adopted for abattoirs to dispose of specified offal from cows, including the brains, by burning them. But spot inspections show that the regulations are not always observed. The US Department of Agriculture said that no processed beef or cattle have been imported into the United States from Britain since 1989 and that mad cow disease has not been detected in this country.
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Infectious Diseases Mortality Rises
The CDC reported recently that the US death rate due to infectious diseases as the underlying cause of death increased 55% from 1980 to 1992, from 41 to 65 deaths per 100,000 population. Age-adjusted mortality from infectious diseases increased 39% during the same period. Infectious diseases mortality increased 25% among those aged 65 years and older and 6.3 times among 25 to 44 year olds. Considered together, infectious diseases were the third leading cause of death in the United States in 1992.
The authors point out that information about infectious diseases usually is presented one disease at a time, causing a fragmented overall view of infectious diseases by obscuring their aggregate impact. This approach can confound public policy decisions, which rest on assessment of infectious disease in the context of other public health or policy issues and may be based more on current estimates than trends. Infectious disease trends are susceptible to rapid shifts, in contrast to other disease categories such as cancer and heart disease. Thus, to anticipate public health threats effectively, these trends must be monitored as well, and policy decisions must take them into account.
The authors note that public health policy during the past 2 decades has been based largely on trends in the earlier part of this century, when mortality from infectious diseases was declining. However, the thesis that infectious diseases would continue to decrease in the United States and other developed countries and be replaced in time by noninfectious causes of death requires reconsideration.
The Institute of Medicine recently provided a conceptual framework for this issue in their report on emerging infections by characterizing the dynamic factors that allow or promote the emergence and reemergence of infectious disease. These include increasing population size and age, changes in human behaviors, and rapid changes in technology and industry, creating new niches for microbial pathogens. These trends call for renewed interest in infectious diseases in the medical and public health communities.
The authors conclude that, despite historical predictions that infectious diseases would wane in the United States, these data show that infectious disease mortality in the United States has been increasing in recent years. This study was reported in the January 17, 1996, issue of the Journal of the American Medical Association (JAMA) as part of a series of articles on emerging infections. In January, JAMA joined 35 other medical journals worldwide to document the occurrence, causes, and consequences of emerging and reemerging infections. This resurgence of
